O-Desmethyl Midostaurin (CGP-62221; CGP62221; O-Desmethyl PKC-412), the O-demethylated metabolite of Midostaurin, may be used as an internal standard for studying the in vivo metabolism of Midostaurin. Midostaurin is an anticancer drug approved in 2017 by FDA to treat acute myeloid leukemia.

纯度：≥98%

CAS：740816-86-8